S
Senseonics Holdings, Inc. Common Stock (SENS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
$10.90
+0.32 (+3.02%)
Market Cap: $579.58M
Last updated: Nov 17, 2026 at 11:05 AM ET
Senseonics Holdings, Inc. Common Stock (SENS) Valuation Multiples
Senseonics Holdings, Inc. Common Stock (SENS) trades at 11.9x sales and 9.2x book value. Its forward P/E is 21.0x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 21.0x |
| Price to sales | 11.9x |
| Price to book | 9.2x |
| PEG | N/A |
| FCF yield | -15.9% |
Valuation History
Over the 7 of the 10 year ends shown that have a P/S, its P/S ranged from 6.4x in 2025 to 754.2x in 2016. 2025 was the lowest of those years.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $5.52 | 6.4x | 3.8x |
| 2024 | $10.47 | 14.8x | N/A |
| 2023 | $11.40 | 13.9x | 8.4x |
| 2022 | $20.60 | N/A | N/A |
| 2021 | $53.40 | N/A | N/A |
| 2020 | $17.44 | N/A | N/A |
| 2019 | $18.32 | 8.2x | N/A |
| 2018 | $51.80 | 22.0x | 6.4x |
| 2017 | $53.20 | 51.9x | 50.2x |
| 2016 | $53.40 | 754.2x | N/A |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SENS
What is SENS's forward P/E ratio?
Senseonics Holdings, Inc. Common Stock has a forward P/E ratio of 21.0x.
Is SENS stock overvalued?
GNG's valuation label for SENS is Fairly valued.
What is SENS's price to sales ratio?
Senseonics Holdings, Inc. Common Stock has a price to sales ratio of 11.9x.
SENS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors